RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fulgent Genetics Stock

Fulgent Genetics ROA 2024

Fulgent Genetics ROA

-0.14

Ticker

FLGT

ISIN

US3596641098

WKN

A2AS4N

In 2024, Fulgent Genetics's return on assets (ROA) was -0.14, a -231.32% increase from the 0.1 ROA in the previous year.

Fulgent Genetics Aktienanalyse

What does Fulgent Genetics do?

Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Fulgent Genetics's Return on Assets (ROA)

Fulgent Genetics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Fulgent Genetics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Fulgent Genetics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Fulgent Genetics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Fulgent Genetics stock

What is the Return on Assets (ROA) of Fulgent Genetics this year?

The Return on Assets (ROA) of Fulgent Genetics is -0.14 undefined this year.

What was the ROA of Fulgent Genetics compared to the previous year?

The ROA of Fulgent Genetics has increased by -231.32% compared to the previous year.

What consequences do high ROA have for investors of Fulgent Genetics?

A high ROA is advantageous for investors of Fulgent Genetics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Fulgent Genetics?

A low ROA can be unfavorable for investors of Fulgent Genetics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Fulgent Genetics affect the company?

An increase in ROA of Fulgent Genetics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Fulgent Genetics impact the company?

A reduction in the ROA of Fulgent Genetics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Fulgent Genetics?

Some factors that can influence the ROA of Fulgent Genetics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Fulgent Genetics important for investors?

The ROA of Fulgent Genetics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Fulgent Genetics take to improve ROA?

To improve ROA, Fulgent Genetics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Fulgent Genetics pay?

Over the past 12 months, Fulgent Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulgent Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulgent Genetics?

The current dividend yield of Fulgent Genetics is .

When does Fulgent Genetics pay dividends?

Fulgent Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulgent Genetics?

Fulgent Genetics paid dividends every year for the past 0 years.

What is the dividend of Fulgent Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulgent Genetics located?

Fulgent Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulgent Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulgent Genetics from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Fulgent Genetics pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Fulgent Genetics in the year 2023?

In the year 2023, Fulgent Genetics distributed 0 USD as dividends.

In which currency does Fulgent Genetics pay out the dividend?

The dividends of Fulgent Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fulgent Genetics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Fulgent Genetics

Our stock analysis for Fulgent Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fulgent Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.